SALGA Profile...................................................................................005 Foreword by the President.............................................................006 Chief Executive Officer's Overview..............................................008 Strategic Overview..........................................................................010 SALGA Mandate...............................................................................011 Members...........................................................................................013 Stakeholders and Partners............................................................023 SALGA Strategy 2022-2027.........................................................015 Organisational结构.................................................................................................................................... 017
Foreword .....................................................................................................3 Introduction ................................................................................................4 Objectives of this strategy .........................................................................5 What is Early Help?......................................................................................5 Our partnership原则..................................................................................................................................................为什么早期的帮助很重要?.....................................................................7 Where are we now?.....................................................................................8 Our partnership...........................................................................................9 Local context............................................................................................ 10 Our vision ................................................................................................. 11 Our values & practice principles.............................................................. 11 Practice principles.................................................................................... 11 Our Priorities ............................................................................................ 12
Foreword ................................................................................................................................................ 4 1.Executive Summary ...................................................................................................................... 6 2.Introduction .................................................................................................................................... 8 2.1.Antimicrobial resistance .......................................................................................................... 8 2.2 Surveillance of antimicrobial resistance .................................................................................. 8 2.3 Jordan National AMR surveillance system (JARSS) .............................................................. 9 3.Methods ........................................................................................................................................ 12 3.1 Data generation ..................................................................................................................... 12 3.2 Data collection ....................................................................................................................... 13 3.3 Data analysis ...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................结果................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 17 4.1患者/孤立特征.........................................................................
Index: 5 Foreword 6 Application of monoclonal antibodies in the management of Kawasaki 7 Genny Elizabeth Segura Alcivar 7 Innovations in fetal surgery for the correction of spine Bifid Lorena Álamos Encalada 36 Anyoly Yanetty Garcia 36 Use of probiotics in the treatment of the colic of the infant 52 YESENIA PAOLA MARTINEZ ALVAREZ 52 MyriamLissethGarcíaVinueza52使用磁性心脏共振出生90 CarolinaEstefaníaPalmaLeguísamo90ThalíaCristinaCarrisinaCarriunPatiñpatiñ
TABLE OF CONTENT CONTENTS PAGES Preface x Foreword by Dean Faculty of Engineering xi Welcoming Message by ICAEMC 2024 Chairman xii Welcoming Message by ICAEMC 2024 Co-Chairman xiii Organizing Committee xiv International Advisory Committee xv Keynote Speaker 1 Improving structure and protection performance of composites for aerospace applications Prof. Dr. Yasir Nawab
前言................................................................................................................................................................................ 1
前言................................................................................................................................................ 3
前言................................................................................................................................................ 2